Literature DB >> 11869930

A strategy to deter blood doping in sport.

Michael J Ashenden.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11869930

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors:  Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Blood boosting.

Authors:  S Leigh-Smith
Journal:  Br J Sports Med       Date:  2004-02       Impact factor: 13.800

Review 3.  Why we should allow performance enhancing drugs in sport.

Authors:  J Savulescu; B Foddy; M Clayton
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

4.  Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping.

Authors:  Cristina Marrocco; Valeria Pallotta; Angelo D'alessandro; Gilda Alves; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

5.  Extracellular Vesicles From Stored Red Blood Cells Convey Heme and Induce Spic Expression on Human Monocytes.

Authors:  Carolinne Souza Amorim; João Alfredo Moraes; Ingrid de Jesus Magdalena; Sheila Gutiérrez López; Ana Carolina Dudenhoeffer Carneiro; Isabelle Karine da Costa Nunes; Luciana Pizzatti; Vinícius Figueiredo Sardela; Francisco Radler Aquino Neto; Luciana Cristina Mirotti; Henrique Marcelo Gualberto Pereira; Mariana Renovato-Martins
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 6.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

7.  The impact of genetics and hormonal contraceptives on the steroid profile in female athletes.

Authors:  Jenny J Schulze; Jenny E Mullen; Emma Berglund Lindgren; Magnus Ericsson; Lena Ekström; Angelica Lindén Hirschberg
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-10       Impact factor: 5.555
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.